Ppgl Pain Management Medication Selection

Pain Management Medication Selection for PPGL Avoiding Hypertensive Crisis Risk

STEP 1 — Gather Information

Collect patient data: metastatic PPGL status, pain location (bone, spinal, soft tissue), pain severity, current medications, history of hypertensive crisis, catecholamine levels, GI symptoms (constipation, nausea/vomiting, ileus), renal/hepatic function, and comorbidities.
Action: Proceed to assess need for antiemetic or analgesic therapy.

STEP 2 — Rule In / Rule Out

Determine if the patient requires antiemetic therapy for nausea/vomiting.

• If yes → Rule in need for safe antiemetic selection.
• If no → Skip antiemetic selection and proceed to analgesic choice.
  Action: Based on presence of nausea/vomiting, move to antiemetic evaluation or direct analgesic selection.

STEP 3 — Classify or Stratify

Classify pain type (nociceptive vs neuropathic) and GI symptom severity (constipation, ileus).

• For neuropathic pain → consider adjuvant agents (e.g., gabapentin, amitriptyline) with caution for hypertensive risk.
• For constipation/ileus → avoid selective α‑blockers (doxazosin) and metoclopramide/domperidone; prefer prochlorperazine, chlorpromazine, or metyrosine.
• For opioid‑induced nausea → avoid metoclopramide/domperidone; use prochlorperazine or chlorpromazine.
  Action: Select medication class based on pain type and GI profile.

STEP 4 — Decide

Choose specific agent:

• For nausea/vomiting → prochlorperazine 5–10 mg IV/PO q6h PRN or chlorpromazine 10–25 mg IV/PO q6h PRN, monitoring for hypotension.
• For severe constipation → metyrosine 0.5–2 g/day divided doses, titrate to effect, monitor catecholamines.
• For baseline pain → opioid (e.g., oxycodone 5–10 mg PO q4–6h PRN) with laxative regimen; avoid NSAIDs if renal impairment.
• If hypertensive crisis occurs → IV phentolamine 5 mg bolus, then infusion 0.1–0.5 mg/kg/h, monitor BP and GI symptoms.
  Action: Prescribe selected medication with monitoring plan.

Clinical Guardrails / Mimics / Pitfalls

Avoid metoclopramide and domperidone due to hypertensive crisis risk; avoid selective α‑blockers (doxazosin, prazosin) for GI symptoms as they are ineffective; use phenoxybenzamine only if available (not in Japan), otherwise rely on injectable phentolamine with strict BP monitoring; opioids may worsen constipation — co‑prescribe laxatives; corticosteroids can trigger crisis — avoid unless essential; monitor for hypotension and GI symptoms during phentolamine use.

Concrete Clinical Example

A 62‑year‑old with metastatic PPGL to lumbar spine reports worsening back pain and nausea. Nausea present → rule in antiemetic need. Pain classified as nociceptive with mild constipation → avoid metoclopramide/domperidone, choose prochlorperazine 10 mg PO q8h PRN for nausea and oxycodone 5 mg PO q4h PRN for pain with senna laxative. No hypertensive crisis observed; pain and nausea controlled after 48 h.

Source: Japan Endocrine Society Clinical Practice Guideline for the Diagnosis and Management of Pheochromocytoma and Paraganglioma 2025, Japan Endocrine Society, 2025, doi:10.1507/endocrj.EJ25-0165